Methylene blue upregulates Nrf2/ARE genes and prevents tau-related neurotoxicity.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Human Molecular Genetics

• Publication date

  2014-07-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/hmg/ddu080PMID 24556215PMCID PMC4065148
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Targeting Nrf2-Mediated Gene Transcription by Extremely Potent Synthetic Triterpenoids Attenuate Dopaminergic Neurotoxicity in the MPTP Mouse Model of Parkinson's Disease

  2013cited by this paper
• Mechanistic basis of phenothiazine-driven inhibition of Tau aggregation.

  2013influential reference
• Aminothienopyridazines and Methylene Blue Affect Tau Fibrillization via Cysteine Oxidation*

  2013cited by this paper
• Cascade of tau toxicity in inducible hippocampal brain slices and prevention by aggregation inhibitors.

  2013cited by this paper
• The oxidative stress hypothesis in Alzheimer's disease.

  2013cited by this paper
• Mechanisms of protein seeding in neurodegenerative diseases.

  2013cited by this paper
• Tau promotes neurodegeneration via DRP1 mislocalization in vivo.

  2012cited by this paper
• Curcumin Suppresses Soluble Tau Dimers and Corrects Molecular Chaperone, Synaptic, and Behavioral Deficits in Aged Human Tau Transgenic Mice*

  2012cited by this paper
• Nrf2-dependent Induction of Proteasome and Pa28αβ Regulator Are Required for Adaptation to Oxidative Stress*

  2012cited by this paper
• Neurometabolic mechanisms for memory enhancement and neuroprotection of methylene blue.

  2012influential reference
• Methylthioninium chloride (methylene blue) induces autophagy and attenuates tauopathy in vitro and in vivo

  2012cited by this paper
• Cysteine reactivity distinguishes redox sensing by the heat-inducible and constitutive forms of heat shock protein 70.

  2012cited by this paper
• A New Link to Mitochondrial Impairment in Tauopathies

  2012cited by this paper
• Age-associated chronic diseases require age-old medicine: role of chronic inflammation.

  2012cited by this paper
• Inhibition of tau aggregation in a novel Caenorhabditis elegans model of tauopathy mitigates proteotoxicity.

  2012cited by this paper
• Methylene Blue as a Cerebral Metabolic and Hemodynamic Enhancer

  2012cited by this paper
• Inflammation in Alzheimer disease-a brief review of the basic science and clinical literature.

  2012cited by this paper
• Methylene Blue Reduced Abnormal Tau Accumulation in P301L Tau Transgenic Mice

  2012cited by this paper
• Redox-active Cu(II)-Aβ causes substantial changes in axonal integrity in cultured cortical neurons in an oxidative-stress dependent manner.

  2012cited by this paper
• Oxidative stress in health and disease: the therapeutic potential of Nrf2 activation.

  2011cited by this paper
• Neuroprotective effect of Nrf2/ARE activators, CDDO ethylamide and CDDO trifluoroethylamide, in a mouse model of amyotrophic lateral sclerosis.

  2011cited by this paper
• Therapeutic Approaches to Delay the Onset of Alzheimer's Disease

  2011cited by this paper
• Methylene Blue Reduces Aβ Levels and Rescues Early Cognitive Deficit by Increasing Proteasome Activity

  2011cited by this paper
• Behavioral deficit, oxidative stress, and mitochondrial dysfunction precede tau pathology in P301S transgenic mice

  2011influential reference
• Oxidative Damage Compromises Energy Metabolism in the Axonal Degeneration Mouse Model of X-Adrenoleukodystrophy

  2011cited by this paper
• "Lest we forget you--methylene blue...".

  2011cited by this paper
• Segment-specific overexpression of redoxins after renal ischemia and reperfusion: protective roles of glutaredoxin 2, peroxiredoxin 3, and peroxiredoxin 6.

  2011cited by this paper
• Astrocytic neuroprotection through induction of cytoprotective molecules; a proteomic analysis of mutant P301S tau-transgenic mouse.

  2011cited by this paper
• SOD1 (Copper/Zinc Superoxide Dismutase) Deficiency Drives Amyloid β Protein Oligomerization and Memory Loss in Mouse Model of Alzheimer Disease*

  2011cited by this paper
• P301S Mutant Human Tau Transgenic Mice Manifest Early Symptoms of Human Tauopathies with Dementia and Altered Sensorimotor Gating

  2011cited by this paper
• Protective Role of Methylene Blue in Alzheimer's Disease via Mitochondria and Cytochrome c Oxidase

  2010cited by this paper
• Mitochondrial DNA background modifies the bioenergetics of NARP/MILS ATP6 mutant cells.

  2010cited by this paper
• Methylene blue fails to inhibit Tau and polyglutamine protein dependent toxicity in zebrafish.

  2010cited by this paper
• Microglia in neurodegenerative disease

  2010cited by this paper
• Triterpenoids CDDO-ethyl amide and CDDO-trifluoroethyl amide improve the behavioral phenotype and brain pathology in a transgenic mouse model of Huntington's disease.

  2010cited by this paper
• N-iminoethyl-L-lysine improves memory and reduces amyloid pathology in a transgenic mouse model of amyloid deposition.

  2010cited by this paper
• Phenothiazine-mediated rescue of cognition in tau transgenic mice requires neuroprotection and reduced soluble tau burden

  2010cited by this paper
• Oxidative stress and aging.

  2010cited by this paper
• Intrahippocampal injection of a lentiviral vector expressing Nrf2 improves spatial learning in a mouse model of Alzheimer's disease

  2009cited by this paper
• Oxidatively modified proteins in Alzheimer’s disease (AD), mild cognitive impairment and animal models of AD: role of Abeta in pathogenesis

  2009cited by this paper
• Number matters: control of mammalian mitochondrial DNA copy number.

  2009cited by this paper
• Oxidatively modified, mitochondria-relevant brain proteins in subjects with Alzheimer disease and mild cognitive impairment

  2009cited by this paper
• Neuroprotective Effects of the Triterpenoid, CDDO Methyl Amide, a Potent Inducer of Nrf2-Mediated Transcription

  2009cited by this paper
• High absolute bioavailability of methylene blue given as an aqueous oral formulation

  2009cited by this paper
• Reduction of oxidative stress, amyloid deposition, and memory deficit by manganese superoxide dismutase overexpression in a transgenic mouse model of Alzheimer's disease

  2009cited by this paper
• Chemical Manipulation of Hsp70 ATPase Activity Regulates Tau Stability

  2009cited by this paper
• Regulation of glutathione synthesis.

  2009cited by this paper
• DNA damage and repair in Alzheimer's disease.

  2009cited by this paper
• Triterpenoid CDDO‐methylamide improves memory and decreases amyloid plaques in a transgenic mouse model of Alzheimer’s disease

  2009cited by this paper
• Curcumin upregulates transcription factor Nrf2, HO-1 expression and protects rat brains against focal ischemia.

  2009cited by this paper
• Involvement of thio-, peroxi-, and glutaredoxins in cellular redox-dependent processes

  2008cited by this paper
• Behavioral, Physiological and Biochemical Hormetic Responses to the Autoxidizable Dye Methylene Blue.

  2008cited by this paper
• Peroxiredoxin 6 in human brain: molecular forms, cellular distribution and association with Alzheimer’s disease pathology

  2008cited by this paper
• Glutaredoxin systems.

  2008cited by this paper
• The Nrf2–ARE Pathway

  2008cited by this paper
• Redox Regulation of Cellular Stress Response in Aging and Neurodegenerative Disorders: Role of Vitagenes

  2007cited by this paper
• NRF2 Modulates Aryl Hydrocarbon Receptor Signaling: Influence on Adipogenesis

  2007cited by this paper
• Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model.

  2007cited by this paper
• Mitochondrial Oxidative Stress Causes Hyperphosphorylation of Tau

  2007cited by this paper
• The brain metabolic enhancer methylene blue improves discrimination learning in rats.

  2007cited by this paper
• Upregulation of thioredoxin system via Nrf2-antioxidant responsive element pathway in adaptive-retinal neuroprotection in vivo and in vitro.

  2007cited by this paper
• Involvement of glutaredoxin-1 and thioredoxin-1 in beta-amyloid toxicity and Alzheimer's disease.

  2006cited by this paper
• Redox Control of Neural Function: Background, Mechanisms, and Significance

  2006cited by this paper
• Involvement of glutaredoxin-1 and thioredoxin-1 in β-amyloid toxicity and Alzheimer's disease

  2006cited by this paper
• Increased levels of 4-hydroxynonenal and acrolein, neurotoxic markers of lipid peroxidation, in the brain in Mild Cognitive Impairment and early Alzheimer's disease.

  2006cited by this paper
• Inflammation in Alzheimer disease: driving force, bystander or beneficial response?

  2006cited by this paper
• The Involvement of Thioredoxin and Thioredoxin Binding Protein‐2 on Cellular Proliferation and Aging Process

  2005cited by this paper
• Memory facilitation by methylene blue: dose-dependent effect on behavior and brain oxygen consumption.

  2005cited by this paper
• Accumulation of filamentous tau in the cerebral cortex of human tau R406W transgenic mice.

  2005cited by this paper
• Emerging roles of thioredoxin cycle enzymes in the central nervous system

  2005cited by this paper
• Lipid peroxidation is an early event in the brain in amnestic mild cognitive impairment

  2005cited by this paper
• Proteomic analysis of glial fibrillary acidic protein in Alzheimer's disease and aging brain.

  2005cited by this paper
• Proteomic and Functional Analyses Reveal a Mitochondrial Dysfunction in P301L Tau Transgenic Mice*

  2005cited by this paper
• Heme oxygenase expression in human central nervous system disorders.

  2004cited by this paper
• Cysteine Oxidation of Tau and Microtubule-associated Protein-2 by Peroxynitrite

  2004cited by this paper
• Mitochondrial Dysfunction and Oxidative Damage in Alzheimer's and Parkinson's Diseases and Coenzyme Q10 as a Potential Treatment

  2004cited by this paper
• Reduction and uptake of methylene blue by human erythrocytes.

  2004cited by this paper
• Thioredoxin-dependent redox regulation of the antioxidant responsive element (ARE) in electrophile response

  2003cited by this paper
• Risk Factors for Alzheimer’s Disease: Role of Multiple Antioxidants, Non-Steroidal Anti-inflammatory and Cholinergic Agents Alone or in Combination in Prevention and Treatment

  2002cited by this paper
• The p38 pathway is activated in Pick disease and progressive supranuclear palsy: a mechanistic link between mitogenic pathways, oxidative stress, and tau.

  2002cited by this paper
• Oxidative Damage Is the Earliest Event in Alzheimer Disease

  2001cited by this paper
• Oxidative stress hypothesis in Alzheimer's disease.

  1997cited by this paper
• [Oxidative stress and aging].

  1997cited by this paper
• Selective inhibition of Alzheimer disease-like tau aggregation by phenothiazines.

  1996cited by this paper
• Evidence for oxidative stress in Pick disease and corticobasal degeneration.

  1995cited by this paper
• Reduction of thiazine dyes by bovine pulmonary arterial endothelial cells in culture.

  1995cited by this paper
• Inhibition of nitric oxide synthesis by methylene blue.

  1993cited by this paper
• Methylene blue as an inhibitor of superoxide generation by xanthine oxidase. A potential new drug for the attenuation of ischemia/reperfusion injury.

  1991cited by this paper
• Methylene blue competes with paraquat for reduction by flavo-enzymes resulting in decreased superoxide production in the presence of heme proteins.

  1988cited by this paper
• Methylene blue directly oxidizes glutathione without the intermediate formation of hydrogen peroxide.

  1985cited by this paper
• The utility of superoxide dismutase in studying free radical reactions. II. The mechanism of the mediation of cytochrome c reduction by a variety of electron carriers.

  1970cited by this paper

• Behaviour profile characterization of PS19 and rTg4510 tauopathy mouse models: A systematic review and a meta-analysis.

  2025cites this paper
• Benfotiamine Ameliorates Streptozotocin-Induced Alzheimer’s Disease in Rats by Modulating Neuroinflammation, Oxidative Stress, and Microglia

  2025cites this paper
• Loliolide combats glutamate-induced neurotoxicity by oxidative stress through MAPK/Nrf2 pathway in hippocampal neuronal cells

  2025cites this paper
• Methylene blue protects oligodendroglial cell models of multiple systems atrophy against hydrogen peroxide-mediated oxidative stress.

  2025cites this paper
• Methylene Blue Attenuates 3-Nitropropionic Acid-Induced Oxidative Stress and Mitochondrial Dysfunction in Striatal Cells: Therapeutic Implications in Huntington’s Disease Neuropathology

  2025cites this paper
• Targeted autophagic clearance of Tau protects against Alzheimer's disease through amelioration of Tau-mediated lysosomal stress

  2025cites this paper
• Twenty years of therapeutic development in tauopathy mouse models: a scoping review

  2025cites this paper
• Synergistic Neuroprotection in Tauopathic Mice via Green-Synthesized Silver Nanoparticles Co-delivering Methylene Blue and Moringa oleifera

  2025cites this paper
• Targeting the Electron Transport System for Enhanced Longevity

  2025cites this paper
• Types of memory, dementia, Alzheimer's disease, and their various pathological cascades as targets for potential pharmacological drugs.

  2024cites this paper
• Phenothiazines: Nrf2 activation and antioxidant effects

  2024cites this paper
• Methylene blue and its potential in the treatment of traumatic brain injury, brain ischemia, and Alzheimer’s disease

  2024cites this paper
• Model organisms for investigating the functional involvement of NRF2 in non-communicable diseases

  2024cites this paper
• Developing theragnostics for Alzheimer's disease: Insights from cancer treatment.

  2024cites this paper
• Hydromethylthionine rescues synaptic SNARE proteins in a mouse model of tauopathies: interference by cholinesterase inhibitors.

  2024cites this paper
• Determine methylene blue based on carbon paste electrode modified with nanoparticles of nickel oxide-nitrogen carbon quantum dots and carbon structures by cyclic voltammetry

  2024cites this paper
• The Effects of Nitric Oxide Synthase Inhibition on Epinephrine-Induced Arrhythmia and Myocardial Damage

  2023cites this paper
• Alzheimer's Disease; Mechanism, Mutations, and Applications of Nano-Medicine.

  2023cites this paper
• Pathophysiological Aspects and Therapeutic Armamentarium of Alzheimer’s Disease: Recent Trends and Future Development

  2023cites this paper
• Unravelling of molecular biomarkers in synaptic plasticity of Alzheimer's Disease: Critical role of the restoration of neuronal circuits.

  2023cites this paper
• Slingshot homolog-1–mediated Nrf2 sequestration tips the balance from neuroprotection to neurodegeneration in Alzheimer’s disease

  2023cites this paper
• Methylene Blue Induces Antioxidant Defense and Reparation of Mitochondrial DNA in a Nrf2-Dependent Manner during Cisplatin-Induced Renal Toxicity

  2023cites this paper
• Activators of Nrf2 to Counteract Neurodegenerative Diseases

  2023cites this paper
• The Role of the Transcription Factor Nrf2 in Alzheimer’s Disease: Therapeutic Opportunities

  2023cites this paper
• Molecular Mechanisms of the Protective Effects of Olive Leaf Polyphenols against Alzheimer’s Disease

  2023cites this paper
• Neuroprotective effects of methylene blue in streptozotocin-induced model of Alzheimer's disease.

  2023cites this paper
• Mitochondrial Lipid Peroxidation Is Responsible for Ferroptosis

  2023cites this paper
• The protective role of Nrf2 on cognitive impairment in chronic intermittent hypoxia and sleep fragmentation mice.

  2023cites this paper
• Ether Lipid-Mediated Antioxidant Defense in Alzheimer’s Disease

  2023cites this paper
• The Investigation of Ameliorating Effect of Methylene Blue on Cisplatin-Induced Neurotoxicity in Female Rats

  2022cites this paper
• Molecular Mechanisms of the Neuroprotective Effect of Methylene Blue

  2022cites this paper
• Oxidative Stress in Tauopathies: From Cause to Therapy

  2022cites this paper
• Basic Leucine Zipper Protein Nuclear factor erythroid 2-related factor 2 as a Potential Therapeutic Target in Brain Related Disorders.

  2022cites this paper
• Bringing the Spotlight to tau and TDP-43 in Frontotemporal Dementia: A Review of Promising Chemical Compounds.

  2022cites this paper
• Conjugates of Methylene Blue with Cycloalkaneindoles as New Multifunctional Agents for Potential Treatment of Neurodegenerative Disease

  2022cites this paper
• HMTM-Mediated Enhancement of Brain Bioenergetics in a Mouse Tauopathy Model Is Blocked by Chronic Administration of Rivastigmine

  2022cites this paper
• Hypochlorous Acid Activating MB‐O to Release Methylene Blue for Photodegrading of Aβ Aggregates

  2021cites this paper
• Tau Oligomers Neurotoxicity

  2021cites this paper
• Behavioural Functions and Cerebral Blood Flow in a P301S Tauopathy Mouse Model: A Time-Course Study

  2021cites this paper
• Upregulation of hemeoxygenase enzymes HO-1 and HO-2 following ischemia-reperfusion injury in connection with experimental cardiac arrest and cardiopulmonary resuscitation: Neuroprotective effects of methylene blue.

  2021cites this paper
• Role of Nrf2 in Synaptic Plasticity and Memory in Alzheimer’s Disease

  2021cites this paper
• Proteomic Analysis of Hydromethylthionine in the Line 66 Model of Frontotemporal Dementia Demonstrates Actions on Tau-Dependent and Tau-Independent Networks

  2021influential citation
• Novel Therapies for Parkinsonian Syndromes–Recent Progress and Future Perspectives

  2021cites this paper
• Intravitreally Injected Methylene Blue Protects Retina against Acute Ocular Hypertension in Rats

  2021cites this paper
• Nrf2 activation putatively mediates clinical benefits of low-dose radiotherapy in COVID-19 pneumonia and acute respiratory distress syndrome (ARDS): Novel mechanistic considerations

  2021cites this paper
• Methylene blue prevents osteoarthritis progression and relieves pain in rats via upregulation of Nrf2/PRDX1

  2021cites this paper
• Phenothiazine-Tacrine Heterodimers: Pursuing Multitarget Directed Approach in Alzheimer's Disease.

  2021cites this paper
• Long-term depression-related tau phosphorylation is enhanced by methylene blue in healthy rat hippocampus

  2021cites this paper
• THE HORMETIC DOSE-RESPONSE MECHANISM: NRF2 ACTIVATION.

  2021cites this paper
• A Brief Overview of Pathological Tau and Inhibitors and Modifiers of Tau Aggregation for Treatment of Tauopathies

  2021cites this paper
• Revisiting the grammar of Tau aggregation and pathology formation: how new insights from brain pathology are shaping how we study and target Tauopathies.

  2021cites this paper
• Title: Oxidative Stress in Alzheimer’s Disease: A Review on Emergent Natural Polyphenolic Therapeutics

  2021cites this paper
• Nrf2 activation putatively mediates clinical benefits of low-dose radiotherapy in COVID-19 pneumonia and acute respiratory distress syndrome (ARDS): Novel mechanistic considerations Radiotherapy and Oncology

  2021cites this paper
• Sevoflurane suppresses oxidation-induced stress and inflammatory responses, via promotion of Nrf2-induced antioxidant signaling

  2020cites this paper
• β-Lactolin, a Whey-Derived Lacto-Tetrapeptide, Prevents Alzheimer’s Disease Pathologies and Cognitive Decline

  2020cites this paper
• An evaluation of hydromethylthionine as a treatment option for Alzheimer’s disease

  2020cites this paper
• Oxidative stress in alzheimer's disease: A review on emergent natural polyphenolic therapeutics.

  2020cites this paper
• Crosstalk between the mTOR and Nrf2/ARE signaling pathways as a target in the improvement of long-term potentiation.

  2020cites this paper
• Concentration-Dependent Activity of Hydromethylthionine on Clinical Decline and Brain Atrophy in a Randomized Controlled Trial in Behavioral Variant Frontotemporal Dementia

  2020cites this paper
• Targeting tau: Clinical trials and novel therapeutic approaches.

  2020cites this paper
• Nrf2 Ablation Promotes Alzheimer's Disease-Like Pathology in APP/PS1 Transgenic Mice: The Role of Neuroinflammation and Oxidative Stress

  2020cites this paper
• Methylene Blue Improves Mitochondrial Function in The Liver of Cholestatic Rats

  2020cites this paper
• Methylene Blue Treatment Enhances Mitochondrial Function and Locomotor Activity in a C57BL/6 Mouse Model of Multiple Sclerosis

  2020cites this paper
• Four-Repeat Tauopathies: Current Management and Future Treatments

  2020cites this paper
• Bioenergetic Impairment of Triethylene Glycol Dimethacrylate- (TEGDMA-) Treated Dental Pulp Stem Cells (DPSCs) and Isolated Brain Mitochondria are Amended by Redox Compound Methylene Blue †

  2020influential citation
• Modulatory effect of methylsulfonylmethane against BPA/γ-radiation induced neurodegenerative alterations in rats: Influence of TREM-2/DAP-12/Syk pathway.

  2020cites this paper
• PROTECTIVE EFFECT OF METHYLENE BLUE AGAINST COPPER OXIDE NANOPARTICLE-INDUCED NEUROBEHAVIORAL TOXICITY.

  2020cites this paper
• Amyotrophic Lateral Sclerosis: Proteins, Proteostasis, Prions, and Promises

  2020cites this paper
• Tau Filament Self-Assembly and Structure: Tau as a Therapeutic Target

  2020cites this paper
• Effect of long-term methylene blue treatment on the composition of mouse gut microbiome and its relationship with the cognitive abilities of mice

  2020cites this paper
• New Insights Into Drug Discovery Targeting Tau Protein

  2020cites this paper
• antioxidants

  2020cites this paper
• Mechanisms of Anticholinesterase Interference with Tau Aggregation Inhibitor Activity in a Tau-Transgenic Mouse Model. Riedel

  2020cites this paper
• Mechanisms of Anticholinesterase Interference with Tau Aggregation Inhibitor Activity in a Tau-Transgenic Mouse Model

  2020cites this paper
• Methylene blue does not bypass Complex III antimycin block in mouse brain mitochondria

  2019cites this paper
• Crosstalk between Oxidative Stress and Tauopathy

  2019cites this paper
• Protective effect of methylene blue on TNBS-induced colitis in rats mediated through the modulation of inflammatory and apoptotic signalling pathways

  2019cites this paper
• Shaping the Nrf2-ARE-related pathways in Alzheimer's and Parkinson's diseases.

  2019cites this paper
• Methylene Blue Inhibits Formation of Tau Fibrils but not of Granular Tau Oligomers: A Plausible Key to Understanding Failure of a Clinical Trial for Alzheimer’s Disease

  2019cites this paper
• A review on complementary and alternative treatments for dementia

  2019cites this paper
• Methylene blue elicits non-genotoxic H2O2 production and protects brain mitochondria from rotenone toxicity.

  2019cites this paper
• Activation of microglia and astrocytes: a roadway to neuroinflammation and Alzheimer’s disease

  2019cites this paper
• Concentration-Dependent Activity of Hydromethylthionine on Cognitive Decline and Brain Atrophy in Mild to Moderate Alzheimer’s Disease

  2019cites this paper
• Azure B affects amyloid precursor protein metabolism in PS70 cells.

  2019cites this paper
• Methylene blue protects against pentylenetetrazole-induced seizures, oxidative stress, and neuronal injury

  2019influential citation
• Repurposing Proteostasis-Modifying Drugs to Prevent or Treat Age-Related Dementia: A Systematic Review

  2018cites this paper
• Phenothiazine antioxidants increase mitochondrial biogenesis and frataxin levels in Friedreich's ataxia cells.

  2018cites this paper
• Role of green tea catechins in prevention of age‐related cognitive decline: Pharmacological targets and clinical perspective

  2018cites this paper
• Cellular stress and AMPK activation as a common mechanism of action linking the effects of metformin and diverse compounds that alleviate accelerated aging defects in Hutchinson-Gilford progeria syndrome.

  2018cites this paper
• Structural Basis of Small Molecule Targetability of Monomeric Tau Protein.

  2018cites this paper
• Benfotiamine treatment activates the Nrf2/ARE pathway and is neuroprotective in a transgenic mouse model of tauopathy

  2018cites this paper
• Lipophilic methylene blue analogues enhance mitochondrial function and increase frataxin levels in a cellular model of Friedreich's ataxia.

  2018cites this paper
• Azure C Targets and Modulates Toxic Tau Oligomers.

  2018cites this paper
• Heme oxygnease‐1 induction by methylene blue protects RAW264.7 cells from hydrogen peroxide‐induced injury

  2018cites this paper
• Immunotherapy for the Treatment of Alzheimer’s Disease

  2017cites this paper
• From Mitochondrial Function to Neuroprotection—an Emerging Role for Methylene Blue

  2017cites this paper
• Potential of Low Dose Leuco-Methylthioninium Bis(Hydromethanesulphonate) (LMTM) Monotherapy for Treatment of Mild Alzheimer’s Disease: Cohort Analysis as Modified Primary Outcome in a Phase III Clinical Trial

  2017cites this paper
• Investigación y terapias en la enfermedad de Alzheimer basadas en beta amiloide y tau

  2017cites this paper
• Anti-Aging Potentials of Methylene Blue for Human Skin Longevity

  2017cites this paper
• Tau-based therapies in neurodegeneration: opportunities and challenges

  2017cites this paper